Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb
Today, a brief rundown of news involving Novartis and AbbVie, as well as updates from Biogen, Merck & Co. and Sanofi that you may have missed. Novartis on Friday reported fourth quarter and full year results that beat analyst forecasts, driven by sales …